Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
Clinical trial NCT05798663 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05798663
- Sponsor
- Alliance Foundation Trials, LLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2026-11-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.